FeesSafety
Pluang+

Anatomic pathology market to grow at 8.09% CAGR, reaching $71.68B by 2033 driven by cancer diagnostics and AI tech

Market News
17 Nov 2026, 17:09 WIB
Globe News Wire
View Source
Bullish
Anatomic pathology market to grow at 8.09% CAGR, reaching $71.68B by 2033 driven by cancer diagnostics and AI tech

The global anatomic pathology market, valued at $38.71 billion in 2025, is projected to grow to $71.68 billion by 2033 at an 8.09% CAGR. Growth is driven by rising cancer cases, increased use of tissue-based diagnostics, and advancements in digital, molecular, and AI-enabled pathology technologies. North America leads the market due to its advanced healthcare infrastructure and research ecosystem. Continued investment in hospitals, labs, and oncology research will further expand market opportunities worldwide.

The global anatomic pathology market is projected to reach $71.68 billion by 2033 with an 8.09% CAGR. For readers following the health sector, here is Pluang's market snapshot as of Nov 17, 2026 22:21 WIB: of 150 priced US health stocks, 37 rose and 110 fell. Notable movers include ERAS at USD 14.43 (-4.50%), MESO at USD 11.90 (-4.42%), and HUM at USD 441.15 (-4.33%).

More News

Global metal pipe market to reach $190B by 2035, driven by construction and oil & gas demand.

Global metal pipe market to reach $190B by 2035, driven by construction and oil & gas demand.

The global metal pipe market is projected to grow at a 4.4% CAGR, reaching $190.4 billion by 2035. Growth is fueled by rising demand in construction, real estate, oil & gas, and infrastructure modernization. Technological advances, sustainability eff...

Market News
Bullish
24 minutes ago
Global biotech market hits $2.02T in 2026, set to triple by 2035 amid record deals and strong Q3 growth.

Global biotech market hits $2.02T in 2026, set to triple by 2035 amid record deals and strong Q3 growth.

The global biotechnology market reached a valuation of USD 2.02 trillion in 2026 and is projected to grow to USD 6.34 trillion by 2035, driven by a 13.61% CAGR. Leading companies like Amgen, Gilead, Regeneron, Vertex, and Moderna reported strong thir...

Bullish
24 minutes ago
Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene Inc. and City of Hope have started a Phase 1 clinical trial testing a new combination therapy for metastatic colorectal cancer patients resistant to standard treatments. The trial evaluates two experimental drugs, ivonescimab and muzastotug (...

Others
Bullish
2 hours ago
RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand Company Ltd. has released its first mobile game, Palazzo Chronicles: Match 3, on the Google Play Store. The free-to-play match-3 puzzle game features over 270 levels where players restore a royal palace set in Risorgimento Italy. This launch...

Others
Bullish
2 hours ago
Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank announced three key leadership appointments to strengthen its Commercial Banking division. Edward Galan will lead Middle Market Lending, Dawn Scocco will manage portfolio and credit risk, and John Maio will head Treasury Management Ser...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App